Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ameriden International is a specialized nutraceutical company that focuses on the research, development, and distribution of high-quality botanical supplements. The company is widely recognized for introducing Rhodiola rosea to the United States market under the brand name Rosavin, emphasizing rigorous standardization and purification processes. Their product portfolio is designed to support the body's response to stress, enhance cognitive function, and bolster the immune system. Ameriden serves both individual consumers and healthcare professionals with laboratory-tested formulations based on traditional herbal medicine and modern scientific validation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ameriden International.